Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.67, No.3, p.528–536, 2020 |
||
Title: MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway | ||
Author: Y. ZHOU, X. M. XU, Y. FENG | ||
Abstract: Oral squamous cell carcinoma (OSCC) is the most common human malignancy worldwide and a high mortality rate. MiR-769-5p has been reported to be downregulated in tissues and blood of OSCC patients. However, the exact roles and pathogenesis of miR-769-5p involved in OSCC remain unclear. The expressions of miR-769-5p and Janus kinase (JAK1) in OSCC tissue and cells were assessed by RT-qPCR and western blot assay. Expressions of apoptotic-related (Bcl-2, Bax and cleaved-caspase 3) and EMT-associated proteins (MMP9, E-cadherin, N-cadherin, and Vimentin) were detected by western blot assay. The effect of miR-769-5p and JAK1 on proliferation, migration, invasion and apoptosis by CCK-8, transwell and flow cytometry assays, respectively. The binding interaction of miR-769-5p and JAK1 were predicted by Targetscan, and demonstrated by dual-luciferase reporter assays. The volume and weight of the tumour were measured in subcutaneous transplantation experiment. MiR-769-5p was downregulated, and JAK1 was upregulated in OSCC tissue and cells. MiR-769-5p restrained Bcl-2, MMP9, N-cadherin, and Vimentin protein level and accelerated Bax, cleaved-caspase 3 and, E-cadherin protein level, while JAK1 partly overturned these effects. Also, miR-769-5p suppressed proliferation, migration, invasion, and increase apoptosis of OSCC, while the reintroduction of JAK1 abolished these effects. Moreover, JAK1 was verified to be the target of miR-769-5p. In addition, miR-769-5p inhibited the development of OSCC cells in vivo. These results indicate that miR-769-5p suppressed OSCC cells development via targeting JAK1/STAT3 pathway, providing an underlying therapeutic method for OSCC. |
||
Keywords: miR-769-5p, JAK1/ STAT3 pathway, oral squamous cell carcinoma | ||
Published online: 15-May-2020 | ||
Year: 2020, Volume: 67, Issue: 3 | Page From: 528, Page To: 536 | |
doi:10.4149/neo_2020_190703N582 |
||
|
download file |
|